CIK 0001653087 · Accelerated filer<br>Smaller reporting company
Alector, Inc.
Sign in to watch- Ticker
- ALEC
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 822933343
- Phone
- 415-231-5660
- Business address
- 131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
- Former names
- Alector LLC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $296,087
- in 3 filings
Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 76 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-10-01 | Romano Gary Chief Medical Officer | Grant or award · Employee Stock Option (right to buy) | +36,000 | 36,000 | ||
| 2023-10-01 | GRASSO MARC Chief Financial Officer | Grant or award | +123,000 | 155,247 | ||
| 2023-10-01 | GRASSO MARC Chief Financial Officer | Grant or award · Employee Stock Option (right to buy) | +41,000 | 41,000 | ||
| 2023-10-01 | Kenkare-Mitra Sara President and Head of R&D | Grant or award | +163,600 | 341,535 | ||
| 2023-10-01 | Kenkare-Mitra Sara President and Head of R&D | Grant or award · Employee Stock Option (right to buy) | +54,500 | 54,500 | ||
| 2023-10-01 | Rosenthal Arnon Chief Executive Officer | Grant or award | +397,600 | 2,043,048 | ||
| 2023-10-01 | Rosenthal Arnon Chief Executive Officer | Grant or award · Employee Stock Option (right to buy) | +132,500 | 132,500 | ||
| 2023-09-11 | Polaris Venture Management Co. VI, L.L.C. 10% owner | Sale | −500,000 | $6.00 | $3.0M | 10,853,817 |
| 2023-09-11 | MCGUIRE TERRANCE Director | Sale | −500,000 | $6.00 | $3.0M | 10,853,817 |
| 2023-09-05 | Rosenthal Arnon Chief Executive Officer | Sale | −5,647 | $5.19 | $29K | 1,645,448 |
| 2023-09-05 | Kenkare-Mitra Sara President and Head of R&D | Sale | −6,214 | $5.19 | $32K | 177,935 |
| 2023-09-05 | Romano Gary Chief Medical Officer | Sale | −2,771 | $5.19 | $14K | 99,349 |
| 2023-09-05 | GRASSO MARC Chief Financial Officer | Sale | −1,114 | $5.19 | $6K | 32,247 |
| 2023-08-22 | MCGUIRE TERRANCE Director | Other disposition | −500,000 | 11,353,817 | ||
| 2023-08-22 | MCGUIRE TERRANCE Director | Other acquisition | +6,429 | 54,996 | ||
| 2023-08-22 | MCGUIRE TERRANCE Director | Other acquisition | +98,533 | 98,553 | ||
| 2023-08-22 | MCGUIRE TERRANCE Director | Other disposition | −98,533 | 0 | ||
| 2023-08-22 | MCGUIRE TERRANCE Director | Other acquisition | +13,133 | 39,399 | ||
| 2023-08-22 | Polaris Venture Management Co. VI, L.L.C. 10% owner | Other disposition | −500,000 | 11,353,817 | ||
| 2023-08-22 | Polaris Venture Management Co. VI, L.L.C. 10% owner | Other acquisition | +98,533 | 98,533 |
Page 9 of 23 · 454 trades